Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Vectura, Skyepharma To Form World Respiratory Leader

This article was originally published in Scrip

Executive Summary

A UK-based global leader in respiratory therapies will be created by Vectura Group PLC's planned purchase of SkyePharma PLC in a friendly, all-stock deal to forge a combined group with estimated market capitalization of just over £1bn, joint sales of £153.9m and profits of around £50.5m.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register